AG
Andrew Guggenhime (PRESIDENT AND CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $573K of PCVX (10,000 sh across 2 lots, as filed), executed Jul 6. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.6M
shares × price, as filed
Last traded
Aug 3
Filed Aug 5
Median ADV $87.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
PCVXRecent filings
PCVXSALE
Vaxcyte, Inc.
View filing →
$539K10,000 sh across 2 lots
Exec Aug 3
Filed Aug 5 · 4:58 PM ET PCVXSALE Vaxcyte, Inc. View filing → $573K
10,000 sh across 2 lots
Exec Jul 6
Filed Jul 6 · 7:31 PM ET PCVXSALE Vaxcyte, Inc. View filing → $530K
10,000 sh × $53.00
Exec Jun 18
Filed Jun 18 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $671K
8,000 sh across 2 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $632K
7,317 sh across 2 lots
Exec Jan 21 2025
Filed Jan 22 2025 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $685K
7,720 sh across 3 lots
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $675K
7,868 sh across 2 lots
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET